Detecting Doxorubicin Damage to Blood Vessels
Author Information
Author(s): Bar-Joseph Hadas, Ben-Aharon Irit, Tzabari Moran, Tsarfaty Galia, Stemmer Salomon M., Shalgi Ruth
Primary Institution: Sackler Faculty of Medicine, Tel-Aviv University
Hypothesis
Can in vivo imaging detect vascular toxicity caused by doxorubicin in mice?
Conclusion
Doxorubicin causes acute vascular toxicity, reducing blood flow in gonadal and femoral vessels.
Supporting Evidence
- Doxorubicin caused a 33% decrease in ovarian blood volume within 3 minutes.
- Testicular blood flow decreased by 40% after doxorubicin administration.
- Femoral arterial blood flow decreased by 23% after doxorubicin administration.
- Paclitaxel did not show any vascular effects.
Takeaway
This study shows that a cancer drug called doxorubicin can hurt blood vessels quickly, which might lead to more problems later.
Methodology
Mice were injected with doxorubicin, and blood flow was measured using ultrasound and fluorescence imaging.
Limitations
The study's findings may not fully translate to humans due to species differences.
Participant Demographics
ICR mature male and female mice, 7–8 weeks old.
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website